Piramal Pharma Limited’s Pharma Solutions business, a Contract Development and Manufacturing Organization (CDMO), announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS). Berdou joins Piramal Pharma Solutions from Lonza, where he was the Global Head of Operations, Cell and Gene Technologies. He has more than two decades of experience across global supply…
The Pharma Solutions division of Piramal Pharma Limited, a leading contract development and manufacturing company (CDMO), announced today that at the company’s pharmaceuticals site in Pithampur, Madhya Pradesh, India, a new production block was commissioned. The new production area, known as the V-Block, can process batch sizes from 150 to 600 kilograms and expands the…
The Pharma Solutions (PPS) division of Piramal Pharma Limited, a contract research, development and manufacturing (CDMO) company, announced that the company has made an investment of millions of dollars to build a world-class, high throughput screening facility that will expand the existing in vitro biology capabilities at its drug discovery services facility in Ahmedabad, India.…
Piramal Pharma Limited (PPL) announced an investment of INR101.77 cr in Yapan Bio Pvt Ltd (Yapan) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment, according to the statement. As PPS continues…
Piramal Pharma Solutions, a leading Contract Development and Manufacturing Organization, announced it has appointed Sumit Garg as Global Chief Information Officer. He will be reporting to both the company’s COO John Fowler as well as Piramal Enterprises’ Group CIO, Viral Gandhi. In this new role, Sumit Garg will be leading the technology vertical, digital transformation…
Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced that PPL has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt Ltd. (Hemmo) for an upfront consideration of INR 775 crores and earn-outs linked to achievement of milestones. As PPS continues to expand and grow…
Bhavesh Gandhi, CIO-Pharma, Piramal Enterprises has resigned from the role and moved on after serving a stint of 5 years at the conglomerate. Gandhi has joined Aarti Industries as SVP, Chief Digital & Information Officer. In his new role, Gandhi will lead the technology and digital teams across manufacturing units. He will look at the…
Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), has announced its plans to expand Michigan facility with additional capacity and new capabilities for the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company is investing ~US$32 million in the facility to keep up with expected demand based on…
Piramal Pharma Solutions, a leading contract development and manufacturing company (CDMO), announced that it has partnered with Epirium Bio in an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high unmet needs. The Piramal Pharma Solutions (PPS) team provides Epirium with an integrated program that includes formulation development, delivery of APIs and…
U.S.-based Carlyle Group Inc recently announced that it has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490mn. Both the companies have jointly announced the transaction in a statement. Piramal Pharma in a statement said that it will use the capital injection to accelerate its…
Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania. According to the terms of the agreement, PEL, through one of its Affiliates,…